Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Influence of a Symptomatic Coronary Artery and Peripheral Arterial Disease on the Oral-enteral Microbiome and Downstream Microbiome-dependent Metabolites

NCT05456802 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT05456802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05456802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Influence of a Symptomatic Coronary Artery and Peripheral Arterial Disease on the Oral-enteral Microbiome and Downstream Microbiome-dependent Metabolites
Lead sponsor
University Hospital, Essen
Phase
Observational
Overall status
Completed
Start date
August 12, 2022
Completion date
April 1, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, coronary artery disease, critical limb ischemia, microbial colonization, myocardial infarction, peripheral arterial disease